Review: taking Nucynta and Lorazepam together


Summary

Drug interactions are reported among people who take Nucynta and Lorazepam together. This review analyzes the effectiveness and drug interactions between Nucynta and Lorazepam. It is created by eHealthMe based on reports of 62 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Nucynta and Lorazepam >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Nucynta

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. (latest outcomes from Nucynta 1,633 users)

Lorazepam

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. (latest outcomes from Lorazepam 46,073 users)

On Jul, 21, 2016

62 people who take Nucynta, Lorazepam are studied.


Number of reports submitted per year:

Nucynta and Lorazepam drug interactions.

Drug effectiveness over time:

Nucynta:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Lorazepam:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 5 people)

Drug effectiveness by gender:

Nucynta:
  • female: 0.0% - (0 of 2 people)
  • male: 50.0% - (1 of 2 people)
Lorazepam:
  • female: 0.0% - (0 of 8 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Nucynta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Lorazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 7 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • diarrhoea
  • sepsis
  • dysphagia
  • dyspnoea
  • erythema
  • hypersensitivity
  • oedema peripheral
  • throat tightness
  • urticaria
  • death
1 - 6 months:
  • vomiting
  • abdominal pain
  • constipation
  • dizziness
  • inflammatory bowel disease
  • apathy
  • dyspepsia
  • completed suicide
6 - 12 months:
  • swollen lymph nodes
  • vomiting
5 - 10 years:
  • swollen lymph nodes
not specified:
  • anxiety
  • hypoglycaemia
  • suicidal ideation
  • cerebrovascular accident
  • abdominal pain
  • dizziness
  • depression
  • suicide attempt
  • completed suicide
  • confusional state

Most common drug interactions by gender *:

female:
  • abdominal pain
  • dizziness
  • constipation
  • inflammatory bowel disease
  • confusional state
  • disorientation
  • apathy
  • dyspepsia
  • dystonia
  • pneumonia
male:
  • anxiety
  • hypoglycaemia
  • suicidal ideation
  • cerebrovascular accident
  • completed suicide
  • depression
  • suicide attempt
  • amnestic disorder
  • diarrhoea
  • dyspnoea

Most common drug interactions by age *:

20-29:
  • platelet count decreased
30-39:
  • hospitalisation
  • swollen lymph nodes
  • withdrawal syndrome
40-49:
  • amnestic disorder
  • depression
  • dystonia
  • somnambulism
  • suicide attempt
  • weight increased
  • anaemia
  • respiratory depression
  • syncope
  • abscess
50-59:
  • anxiety
  • hypoglycaemia
  • suicidal ideation
  • cerebrovascular accident
  • pneumonia
  • confusional state
  • dizziness
  • dry mouth
  • oedema peripheral
  • ascites
60+:
  • urticaria
  • dysphagia
  • apathy
  • dyspepsia
  • abdominal pain
  • constipation
  • dizziness
  • inflammatory bowel disease
  • completed suicide
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Nucynta and Lorazepam?

Can you answer these questions?

More questions for: Nucynta, Lorazepam

You may be interested in these reviews

More reviews for: Nucynta, Lorazepam

On eHealthMe, Nucynta (tapentadol hydrochloride) is often used to treat pain. Lorazepam (lorazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.